Mechanisms of 17 β-oestradiol induced vasodilatation in isolated pressurized rat small arteries

British Journal of Pharmacology

Volumn 129, Issue 3, 2000, Pages 555-565

  Shaw, Linda ^a   Taggart, Michael J ^a   Austin, Clare ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

17 oestradiol; Tone; Vascular

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYCLOHEXIMIDE; ESTRADIOL; FULVESTRANT; INDOMETACIN; N(G) NITROARGININE; POTASSIUM ION; WORTMANNIN;

ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033979625     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703084     Document Type: Article

References (63)

1. Abraham, G.E., Odell, W.D., Swerdloff, R.S. & Happer, K. (1972). Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J. Clin. Endocr., 34, 312-318.
2. Andersen, H.L., Weis, J.U., Fjalland, B. & Korsgaard, N. (1999). Effect of acute and long-term treatment with 17 β-estradiol on the vasomotor responses in the rat aorta. Br. J. Pharmacol., 126, 159-168.
3. Barrett-Connor, E. & Bush, T.L. (1991). Estrogen and coronary heart disease in women. J. Am. Med. Assoc., 265, 1861-1867.
4. Bayard, F., Clamens, S., Meggetto, F., Blaes, N., Delsol, G. & Faye, J.C. (1995). Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology, 136, 1523-1529.
5. Beck, R., Bertolino, S., Abbot, S.E., Aaronson, P.I. & Smirnov, S.V. (1998). Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ. Res., 83, 923-931.
6. Benten, W.P.M., Lieberherr, M., Giese, G. & Wunderlich, F. (1998). Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Letts., 422, 349-353.
7. Beyer, C. & Raab, H. (1998). Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores. Eur. J. Neurosci., 10, 255-262.
8. Bression, D., Michard, M., Le Dafniet, M., Pagesy, P. & Peillon, F. (1986). Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology, 119, 1048-1051.
9. Brown-Grant, K., Exley, D. & Naftolin, F. (1970). Peripheral plasma oestradiol and lutenizing hormone concentrations during the oestrous cycle of the rat. J. Endocr., 48, 295-296.
10. Bush, T.L., Barrett-Connor, E., Cowan, L.D., Criqui, M.H., Wallace, R.B., Suchinddran, C.M., Tyroler, H.A. & Rifkind, B.M. (1987). Cardiovascular mortality and noncontraceptive use of oestrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation, 75, 1102-1109.
11. Bush, T.L., Cowan, L.D. & Barrett-Connor, E. (1983). Estrogen use and all-cause mortality: preliminary results from the Lipid Research Clinics Program Follow-up Study. JAMA, 249, 814-820.
12. Cockell, A.P. & Poston, L. (1997). 17 β-oestradiol stimulates flow-induced vasodilatation in isolated small mesenteric arteries from prepubertal female rats. Am. J. Obstet. Gynecol., 177, 1432-1438.
13. Collins, P., Rosano, G.M.C., Sarrel, P.M., Ulrich, L., Adamopoulos, S., Beale, C.M., McNeill, J.G. & Poole-Wilson, P.A. (1995). 17 β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92, 24-30.
14. Davidson, N.E. & Lippman, M.E. (1989). The role of estrogens in growth regulation of breast cancer. Crit. Rev. Oncol., 1, 89-111.
15. De Goeij, A.F.P.M., Van Zeeland, J.K., Beek, C.J. & Bosman, F.T. (1986). Steroid-bovine serum albumin conjugates: molecular characterisation and their interaction with androgen and estrogen receptors. J. Steroid Biochem., 24, 1017-1031.
16. Dunn, W.R., Wellman, G.C. & Bevan, J.A. (1994). Enhanced resistance artery sensitivity to agonists under isobaric compared with isometric conditions. Am. J. Physiol., 266, H147-H155.
17. Falloon, B.J., Stephens, N., Tulip, J.R. & Heagerty, A.M. (1995). Comparison of small artery sensitivity and morphology in pressurised and wire-mounted preparations. Am. J. Physiol., 268, H670-H678.
18. Geary, G.G., Krause, D.N. & Duckles, S.P. (1998). Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am. J. Physiol., 275, H292-H300.
19. Gilligan, D.M., Badar, D.M., Panza, J.A., Quyyumi, A.A. & Cannon, R.O. (1995). Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am. J. Cardiol., 75, 264-268.
20. Gilligan, D.M., Quyyumi, A.A. & Cannon, R.O. (1994). Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation, 89, 2545-2551.
21. Gong, M.C., Fuglsang, A., Alessi, D., Kobayashi, S., Cohen, P., Somlyo, A.V. & Somlyo, A.P. (1992). Arachidonic acid inhibits myosin light chain phosphatase and sensitises smooth muscle to calcium. J. Biol. Chem., 267, 21492-21498.
22. Gu, Q. & Moss, R.L. (1998). Novel mechanism for non-genomic action of 17 β-oestradiol on kainate-induced currents in isolated rat CA1 hippocampal neurones. J. Physiol., 506, 745-754.
23. Herrington, D.M., Braden, G.A., Williams, J.K. & Morgan, T.M. (1994). Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol., 73, 951-952.
24. Izzard, A.S., Bund, S.J. & Heagerty, A.M. (1996). Myogenic tone in mesenteric arteries from spontaneously hypertensive rats. Am. J. Physiol., 270, H1-H6.
25. Jiang, C., Sarrel, P.M., Lindsay, D.C., Poole-Wilson, P.A. & Collins, P. (1991). Endothelium-dependent relaxation of rabbit coronary artery by 17 β-oestradiol in vivo. Br. J. Pharmacol., 104, 1033-1037.
26. Kakus, R., Varbiro, S., Szekas, B., Nadasy, G.L., Acs, N. & Monos, E. (1998). Direct relaxing effect of estradiol-17beta and progesterone on rat saphenous artery. Microvasc. Res., 56, 139-143.
27. Kitazawa, T., Hamada, E., Kuazawa, K. & Gaznabi, A.K.M. (1997). Non-genomic mechanism of 17 β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J. Physiol., 499, 497-511.
28. Landers, J.P. & Spelsberg, T.C. (1992). New concepts in steroid hormone action: transcription factors, protooncogenes, and the cascade model for steroid regulation of gene expression. Crit. Rev. Euk. Gene Exp., 2, 19-63.
29. Le Mellay, V., Grosse, B. & Lieberherr, M. (1997). Phospholipase C β and membrane action of calcitriol and estradiol. J. Biol. Chem., 272, 11902-11907.
30. Lin, A.L. & Shain, S.A. (1985). Estrogen mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis, 5, 668-677.
31. Losordo, D.W., Kearney, M., Kim, E.A., Jekanowski, J. & Isner, J.M. (1994). Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation, 89, 1501-1510.
32. Magness, R.R. & Rosenfeld, C.R. (1976). Local and systemic estradiol-17β: effects on uterine and systemic vasodilatation. Am. J. Physiol., 256, E536-542.
33. Makela, S., Savolainen, H., Aavik, E., Myllarniemi, M., Strauss, L., Taskinen, E., Gustafsson, J.A. & Hayry, P. (1999). Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc. Nat. Acad. Sci., 96, 7077-7082.
34. McNeill, A.M., Duckles, S.P. & Krause, D.N. (1996). Relaxant effects of 17 beta-estradiol in the rat tail artery are greater in females than males. Eur. J. Pharmacol., 308, 305-309.
35. Mermelstein, P.G., Becker, J.B. & Surmeier, D.J. (1996). Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci., 16, 595-604.
36. Mugge, A., Riedel, M., Barton, M., Kuhn, M. & Lichtlen, P.R. (1993). Endothelium independent relaxation of human coronary arteries by 17 β-oestradiol in vitro. Cardiovasc. Res., 27, 1939-1942.
37. Mulvany, M.J. & Halpern, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
38. Nadal, A., Rovira, J.M., Laribi, O., Leon-Quinto, T., Andreu, E., Cristina, R. & Soria, B. (1998). Rapid insulinotropic effect of 17 β-estradiol via a plasma membrane receptor. FASEB J., 12, 1341-1348.
39. Nagano, N., Imaizumi, Y. & Watanabe, M. (1995). Modulation of calcium channel currents by arachidonic acid in single smooth muscle cells from vas deferens of the guinea-pig. Br. J. Pharmacol, 116, 1887-1893.
40. 2+ currents in aortic smooth muscle cells. Eur. J. Pharmacol., 294, 625-635.
41. Nenci, I., Marchettt, E., Marzola, A. & Fabris, G. (1981). Affinity chromatography visualises specific estrogen receptor binding sites on plasma membrane of breast cancer cells. J. Steroid Biochem., 14, 1139-1146.
42. 3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology, 140, 3805-3814.
43. Otter, D. & Austin, C. (1998). Effects of 17 β-oestradiol on rat isolated coronary and mesenteric artery tone: Involvement of nitric oxide. J. Pharm. Pharmacol., 50, 531-538.
44. Pace, P., Taylor, J., Suntharalingam, S., Coombes, R.C. & Ali, S. (1997). Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor χ. J. Biol. Chem., 41, 25832-25838.
45. Pappas, T.C., Gametchu, B. & Watson, C.S. (1995). Membrane estrogen receptors identified by multiple antibody labelling and impeded-ligand binding. FASEB J., 9, 404-410.
46. Pietras, R.J. & Szego, C.M. (1977). Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature, 265, 69-72.
47. Plane, F. & Garland, C.J. (1996). Influence of contractile agonists on the mechanism of endothelium-dependent relaxation of rat isolated mesenteric artery. Br. J. Pharmacol., 119, 191-193.
48. Razandi, M., Pedram, A., Greene, G.L. & Levin, E.R. (1999). Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in chinese hamster ovary cells. Molec. Endocrinol., 13, 307-319.
49. Register, T.C. & Adams, M.R. (1998). Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J. Steroid Biochem., 64, 187-191.
50. Reis, S.E., Gloth, S.T., Blumenthal, R.S., Resar, J.R., Zacur, H.A., Gerstenblith, G. & Brinker, J.A. (1994). Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation, 89, 52-60.
51. Rosenfeld, C.R., Morriss, F.H., Barraglia, F.C., Makowski, E.L. & Meschia, G. (1976). Effect of estradiol-17 β on blood flow to reproductive and nonreproductive tissue in pregnant ewes. Am. J. Obstet. Gynecol., 124, 618-629.
52. Sarrel, P.M. (1990). Ovarian hormones and the circulation. Maturitas, 12, 287-298.
53. Saunders, P.T.K., Maguire, S.M., Gaughan, J.& Millar, M.R. (1997). Expression of oestrogen receptor beta (ERβ) in multiple rat tissues visualised by immunohistochemistry. J. Endocrinol., 154, R13-R16.
54. Skarsgard, P., Van Breemen, C. & Laher, I. (1997). Estrogen regulates myogenic tone in pressurised cerebral arteries by enhanced basal release of nitric oxide. Am. J. Physiol., 273, H2248-H2256.
55. Sudhir, K., Chou, T.M., Mullen, W.L., Hausmann, D., Collins, P., Yock, P.G. & Chatterjee, K. (1995). Mechanisms of estrogen-induced vasodilatation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol., 26, 807-814.
56. 2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 120-127.
57. Urakami-Harasawa, L., Shimokawa, H., Nakashima, M., Egashira, K. & Takeshita, A. (1997). Importance of endothelium-derived hyperpolarising factor in human arteries. J. Clin. Invest., 100, 2793-2799.
58. Van Buren, G.A., Yang, D. & Clark, K.E. (1992). Estrogen-induced uterine vasodilatation is antagonised by 1-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstet. Gynecol., 167, 828-833.
59. Van Den Bemd, G.J., Kuiper, G.G., Pols, H.A & Van Leeuwen, J.P. (1999). Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Biochem. Biophys. Res. Commun., 22, 1-5.
60. 2+ entry process on H1-histaminoceptor stimulation in DDT1 MF-2 cells. Biochem. J., 305, 859-864.
61. Wakeling, A.E. & Bowler, J. (1992). ICI 182,780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol., 43, 173-177.
62. Waring, P. (1990). DNA fragmentation induced by macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J. Biol. Chem., 265, 14476-14480.
63. Williams, J.K., Adams, M.R. & Klopfenstein, H.S. (1990). Estrogen modulates responses of atherosclerotic coronary arteries. Circulation, 81, 1680-1687.